iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

ICRA assigns A1+ rating on Astec LifeSciences' Rs300 crore Commercial Paper programme; Stock trades higher

31 Mar 2022 , 02:05 PM

ICRA Limited on March 29, 2022, has assigned an ‘ICRA A1+’ rating to the enhanced Commercial Paper programme of Rs100 crore of Astec LifeSciences Limited.

The credit rating agency also reaffirmed its ‘ICRA A1+’ rating for the existing Rs200 crore Commercial Paper programme of the Company.

Considering the above, the credit rating assigned by ICRA Limited to the Company for its entire Commercial Paper programme of Rs300 is ‘ICRA A1+’ rating.

At around 2.07 pm, Astec Lifesciences Ltd was trading at Rs1,796 per share up by Rs24.3 or 1.37% from its previous closing of Rs1,771.70 per share on the BSE.

Related Tags

  • Astec LifeSciences Limited
  • Astec LifeSciences news
  • Astec LifeSciences rating
  • Astec LifeSciences share price
  • Astec LifeSciences stock price
  • credit rating
  • ICRA
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.